Abstract
As therapeutic agents, morphine and morphinelike drugs are indispensable, but these same agents are liable to nontherapeutic self-ingestion by segments of the population. Society has condemned this self-ingestion and its associated behaviors and has invoked stringent legal mechanisms controlling the manufacture and distribution of morphinelike drugs. In an attempt to develop analgesics, antitussives, and antidiarrheals that were devoid of those properties of morphine leading to abuse, a large number of drugs have been synthesized and studied. Few drugs have been discovered which exhibit this selectivity, but many have been found that are pharmacologically equivalent to morphine with a potential similar to morphine for abuse.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Andrews, H.L., Himmelsbach, C.K.: Relation of the intensity of the morphine abstinence syndrome to dosage. J. Pharmacol. exp. Ther. 81, 288–293 (1944)
Bazell, R.J.: Drug abuse: Methadone becomes the solution and the problem. Science 179, 772–775 (1973)
Beaver, W.T., Wallenstein, S.L., Houde, R.W., Rogers, A.: A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenteral administered methadone. Clin. Pharmacol. Ther. 8, 415–426 (1967)
Beaver, W.T., Wallenstein, S.L., Houde, R.W., Rogers, A.: A comparison of the analgesic effects of profadol and morphine in patients with cancer. Clin. Pharmacol. Ther. 10, 314–319 (1969)
Beecher, H.K.: Measurement of Subjective Responses. New York: Oxford University Press 1959
Blumberg, H., Dayton, H.B.: Naloxone, naltrexone, and related noroxymorphones. In: Braude, M.C., Harris, L.S., May, E.L., Smith, J.P., Villarreal, J.E. (Eds.): Narcotic Antagonists. Advances in Biochemical Psychopharmacology, Vol.8. New York: Raven Press 1974
Chabalko, J., LaRosa, J.C., DuPont, R.L.: Death of methadone users in the District of Columbia. Int. J. Addict. 8, 897–908 (1973)
Chambers, C.D., Inciardi, J.A.: An empirical assessment of the availability of illicit methadone. Proceedings of the Fourth National Conference on Methadone Treatment, San Francisco, California, pp. 149–151. New York: National Association for the Prevention of Addiction to Narcotics 1972
Chambers, C.D., Moffett, A.D., Cuskey, W.R.: Five patterns of Darvon abuse. Int. J. Addict. 6, 173–189 (1971)
Cochin, J., Harris, L.: Synthetic Substitutes for Opiate Alkaloids. Report prepared for Committee on Problems of Drug Dependence, National Research Council, Washington, D.C., under contract No. BNDD 72-9 between the National Academy of Sciences and Bureau of Narcotics and Dangerous Drugs, 1975
Davenport, L.F.: The abuse of codeine. Publ. Hlth. Rep. (Wash.), Suppl. 145 (1938)
Eddy, N.B.: Dilaudid (dihydromorphinone hydrochloride). J. Amer. med. Ass. 100, 1031–1035 (1933)
Eddy, N.B.: The history of the development of narcotics. Law Contemp. Prob. 22, 3–8 (1957)
Eddy, N.B.: The National Research Council involvement in the opiate problem, 1928–1971. Washington, D.C.: National Academy of Sciences 1973
Eddy, N.B., Himmelsbach, C.K.: Experiments on the tolerance and addiction potentialities of dihydrodesoxymorphine-D (“Desomorphine”). Publ. Hlth. Rep. (Wash.), Suppl. 118 (1936)
Finney, D.J.: Statistical method in biological assay. New York: Hafner Publishing Company 1964
Forrest, W.H., Jr.: Report of the Veterans Administration Cooperative Analgesic Study. Presented at 30th Meeting, Committee on Problems of Drug Dependence, National Research Council, Indianapolis, Indiana, 1968
Forrest, W.H., Jr.: Report of the Veterans Administration cooperative analgesic study. Presented at 32nd meeting, Committee on Problems of Drug Dependence, National Research Council, Washington, D.C. 1970
Forrest, W.H., Brown, C.R., Gold, M., Mahler, D.L., Schettini, A., Teutsch, G., James, K.E.: Report of the Veterans Administration cooperative analgesic study. Presented at 35th meeting, Committee on Problems of Drug Dependence, National Research Council, Mexico City, Mexico 1974
Fraser, H.F.: Addiction liability of narcotine. Presented at 14th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Rensselaer, N.Y. 1954
Fraser, H.F.: Addictive potentialities of hexamethyleneimines. Fed. Proc. 15, 423 (1956)
Fraser, H.F.: Addictiveness of 1,2-dimethyl-3-phenyl-3-propionoxy-pyrrolidine hydrochloride (ARC-I-0-1). Bull. Narcot. 16, 37–43 (1964)
Fraser, H.F., Essig, C.F., Wolbach, A.B.: Evaluation of carisoprodol and phenyramidol for addictiveness. Bull. Narcot. 13, 1–5 (1961a)
Fraser, H.F., Isbell, H.: Addiction liabilities of morphinan, 6-methyldihydromorphme and dihydrocodeinone. J. Pharmacol. exp. Ther. 100, 128–134 (1950)
Fraser, H.F., Isbell, H.: Actions and addiction liabilities of alphaacetylmethadols in man. J. Pharmacol. exp. Ther. 105, 458–465 (1952)
Fraser, H.F., Isbell, H.: Failure of cortisone and ACTH in treatment of the morphine abstinence syndrome. Ann. intern. Med. 38, 234–238 (1953)
Fraser, H.F., Isbell, H.: Addictive properties of morphine derivatives. J. Pharmacol. exp. Ther. 113, 21–22 (1955a)
Fraser, H.F., Isbell, H.: Morphine antagonists. Fed. Proc. 14, 340 (1955b)
Fraser, H.F., Isbell, H.: Reports on addiction liability tests of new substances. Presented at 17th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C., 1956 a
Fraser, H.F., Isbell, H.: Work of the NIMH Addiction Research Center, PHS Hospital, Lexington, Kentucky. Calendar Year 1955. Presented at the 17th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C., 1956 b
Fraser, H.F., Isbell, H.: Chlorpromazine and reserpine. (A) Effects of each and of combinations of each with morphine. (B) Failure of each in treatment of abstinence from morphine. Arch. Neurol. Psychiat. (Chic.) 76, 257–262 (1956c)
Fraser, H.F., Isbell, H.: Addiction liability of new analgesics. Presented at 18th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Indianapolis, Ind., 1957
Fraser, H.F., Isbell, H.: Human pharmacology and addiction liability of certain compounds related to morphine or codeine. Presented at 19th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C., 1958 a
Fraser, H.F., Isbell, H.: Progress report. NIMH Addiction Research Center, PHS Hospital, Lexington, Kentucky. Presented at 19th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C., 1958 b
Fraser, H.F., Isbell, H.: Addiction liabilities of (a) dl-2’-hydroxy-5,9-dimethyl-2-(phenethyl)-6,7-benzomorphan HBr (NIH-7519) and (b) l-3-hydroxy-N-phenacyl-morphinan methane sulfonate (NIH-7525). Presented at 20th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C., 1959 a
Fraser, H.F., Isbell, H.: Addictiveness of trifluoperazine (SKF-5019). Presented at 20th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C., 1959 b
Fraser, H.F., Isbell, H.: Human pharmacology and addiction liabilities of phenazocme and levophenacylmorphan. Bull. Narcot. 12, 15–23 (1960a)
Fraser, H.F., Isbell, H.: Human pharmacology and addictiveness of ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-piperidine carboxylate hydrochloride (R-1132, diphenoxylate). Presented at 21st meeting, Committee on Drug Addiction and Narcotics, National Research Council, Philadelphia, Pennsylvania 1960 b
Fraser, H.F., Isbell, H.: Pharmacology and addiction liability of dl-and d-propoxyphene. Bull. Narcot. 12, 9–14 (1960c)
Fraser, H.F., Isbell, H.: Human pharmacology and addictiveness of ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-piperidme carboxylate (R-1132, diphenoxylate). Bull. Narcot. 13, 29–43 (1961a)
Fraser, H.F., Isbell, H.: II. Human pharmacology and addictiveness of certain dextroisomers of opioids: 1. d-3-hydroxy-N-phenethylmorphinan, 2. d-3-methoxy-N-phenethylmorphinan, and 3. d-methadone. Presented at 23rd meeting, Committee on Drug Addiction and Narcotics, National Research Council, New York, New York 1961 b
Fraser, H.F., Isbell, H.: Human pharmacology and addictiveness of certain dextroisomers of synthetic analgesics: I. d-3-hydroxy-N-phenethylmorphinan, II. d-3-methoxy-N-phenethylmorphinan, III. d-methadone. Bull. Narcot. 14, 25–35 (1962)
Fraser, H.F., Isbell, H., Nash, T.L., van Horn, G.D.: Use of miotic effects in evaluating analgesic drugs in man. Arch. int. Pharmacodyn. 98, 443–451 (1954)
Fraser, H.F., Isbell, H., Rosenberg, D.E., Wolbach, A.B.: Annual report of the National Institute of Mental Health Addiction Research Center. Presented at 24th meeting, Committee on Drug Addiction and Narcotics, National Research Council, New York, New York 1962
Fraser, H.F., Isbell, H., Van Horn, G.D.: Effects of morphine as compared with a mixture of morphine and diaminophenylthiazole (Daptazole). Presented at 18th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Indianapolis, Indiana 1957 a
Fraser, H.F., Isbell, H., Van Horn, G.D.: Effects of morphine as compared with a mixture of morphine and diaminophenylthiazole (Daptazole). Anesthesiology 18, 531–535 (1957b)
Fraser, H.F., Isbell, H., Van Horn, G.D.: Human pharmacology and addiction liability of norcodeine. J. Pharmacol. exp. Ther. 129, 172–177 (1960a)
Fraser, H.F., Isbell, H., Wolbach, A.B.: Addictiveness of new synthetic analgesics. I. Benzimidazole derivatives: (a) 2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole methane sulfonate (NIH-7586, ARC I-G-1), and (b) 2-(p-ethoxybenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole hydrochloride (NIH-7607, ARC I-G-2). II. (-) 3-hydroxy-N-(3, 3-dimethylallyl)-morphinan hydrobromide (NIH-7446). III. (a) N-(methyl-2-piperidinoethyl-propionanilide hydrochloride) (Phenampromid), and (b) N-(2-(methyl)-phenethylamino)-propyl)-propionanilide sulfate (Diampromid). Presented at 21st meeting, Committee on Drug Addiction and Narcotics, National Research Council, Philadelphia, Pennsylvania 1960 b
Fraser, H.F., Martin, W.R., Wolbach, A.B., Isbell, H.: Addiction liability of 1-(p-chlorophenethyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline (I-K-1, No.4-1778/1). Presented at 23rd meeting, Committee on Drug Addiction and Narcotics, National Research Council, New York, New York 1961 b
Fraser, H.F., Martin, W.R., Wolbach, A.B., Isbell, H.: Addiction liability of an isoquinoline analgesic, 1-(p-chlorophenethyl)-2-methyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline. Clin. Pharmacol. Ther. 2, 287–299 (1961c)
Fraser, H.F., Rosenberg, D.E.: Observations on the human pharmacology and addictiveness of methotrimeprazine. Clin. Pharmacol. Ther. 4, 596–601 (1963a)
Fraser, H.F., Rosenberg, D.E.: Preliminary report on the human pharmacology and addiction liability of 2-cyclopropylmethyl-2’-hydroxy-5,9-dimethyl-6,7-benzomorphan (ARC II-C-3); (WIN 20,740). Presented at 25th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Ann Arbor, Michigan 1963 b
Fraser, H.F., Rosenberg, D.E.: Studies on addiction liability of 2’-hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan (II-C-2): a narcotic antagonist. Presented at 25th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Ann Arbor, Michigan 1963c
Fraser, H.F., Rosenberg, D.E.: Studies on the human addiction liability of 2-hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan (WIN 20,228); a weak narcotic antagonist. (II-C-2). J. Pharmacol. exp. Ther. 143, 149–156 (1964)
Fraser, H.F., Rosenberg, D.E., Isbell, H.: Progress report of the NIMH Addiction Research Center on certain analgesic drugs. Presented at 25th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Ann Arbor, Michigan 1963
Fraser, H.F., Van Horn, G.D., Isbell, H.: Studies on N-allylnormorphine in man: Antagonism to morphine and heroin and effects of mixtures of N-allylnormorphine and morphine. Amer. J. med. Sci. 231, 1–8 (1956)
Fraser, H.F., Van Horn, G.D., Martin, W.R., Wolbach, A.B., Isbell, H.: Methods for evaluating addiction liability. (A) “Attitude” of opiate addicts toward opiate-like drugs. (B) A short-term “direct” addiction test. J. Pharmacol. exp. Ther. 133, 371–387 (1961d)
Fraser, H.F., Wolbach, A.B.: The addiction liability of alpha-dl-3-acetoxy-4,4-diphenyl-6-methylamino-heptane hydrochloride (NIH-7667, ARC I-C-25) and 6-acetyl-3-ethoxy-dihydromorphine (NIH-7623, ARC-I-A-38). Presented at 23rd meeting, Committee on Drug Addiction and Narcotics, National Research Council, New York, New York 1961
Gorodetzky, C.W., Martin, W.R.: A comparative study of fentanyl, droperidol and morphine. Presented at 27th meeting, Committee on Problems of Drug Dependence, National Research Council, Houston, Texas 1965 a
Gorodetzky, C.W., Martin, W.R.: A comparison of fentanyl, droperidol and morphine. Clin. Pharmacol. Ther. 6, 731–739 (1965b)
Greene, M.H., DuPont, R.L.: Heroin addiction trends. Amer. J. Psychiat. 131, 545–550 (1974)
Greene, M.H., Brown, B.S., DuPont, R.L.: Illicit methadone abuse in Washington, D.C.: In: Senay, E., Shorty, V., Alksne, H. (Eds.): Developments in the field of drug abuse. Cambridge, Mass.: Schenkman Publishing Co., Inc. 1974
Haertzen, C.A.: Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychol. Rep. 18, 163–194 (1966)
Haertzen, C.A.: Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI). Psychopharmacologia (Berl.) 18, 366–377 (1970)
Haertzen, C.A.: An overview of Addiction Research Center Inventory Scales (ARCI): an appendix and manual of scales. DHEW Publication No. (ADM) 74-92. Rockville, Maryland: National Institute on Drug Abuse 1974
Haertzen, C.A., Hill, H.E., Belleville, R.E.: Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs. Psychopharmacologia (Berl.) 4, 155–166 (1963)
Haertzen, C.A., Hooks, N.T., Jr.: Changes in personality and subjective experiences associated with the chronic administration and withdrawal of opiates. J. nerv. ment. Dis. 148, 606–614 (1969)
Hill, H.E., Haertzen, C.A., Wolbach, A.B., Miner, E.J.: The Addiction Research Center Inventory. Standardization of scales which evaluate subjective effects of morphine, amphetamime, pentobarbital, alcohol, LSD-25, pyrahexyl and chlorpromazine. Psychopharmacologia (Berl.) 4, 167–183 (1963a)
Hill, H.E., Haertzen, C.A., Wolbach, A.B., Miner, E.J.: The Addiction Research Center Inventory: I. Items comprising empirical scales for seven drugs. II. Items which do not differentiate placebo from any drug condition. Psychopharmacologia (Berl.) 4, 184–205 (1963b)
Himmelsbach, C.K.: Addiction liability of codeine. J. Amer. med. Ass. 103, 1420 (1934)
Himmelsbach, C.K.: Clinical studies of drug addiction. I. The absence of addiction liability in “Perparin”. Publ. Hlth Rep. (Wash.), Suppl. 122 (1937a)
Himmelsbach, C.K.: Clinical studies of drug addiction. II. “Rossium” treatment of drug addiction. Publ. Hlth Rep. (Wash.), Suppl. 125 (1937b)
Himmelsbach, C.K.: Studies of certain addiction characteristics of (a) dihydromorphine (“paramorphan”), (b) dihydrodesoxymorphine-D (“desomorphine”), (c) dihydrodesoxycodeine-D (“desocodeine”) and (d) methyldihydromorphinone (“metopon”). J. Pharmacol. exp. Ther. 67, 239–249 (1939)
Himmelsbach, C.K.: Thiamine in the treatment of the morphine abstinence syndrome in man. J. Pharmacol. exp. Ther. 70, 293–296 (1940)
Himmelsbach, C.K.: The effects of certain chemical changes on the addiction characteristics of drugs of the morphine, codeine series. J. Pharmacol. exp. Ther. 71, 42–48 (1941)
Himmelsbach, C.K.: Studies of the addiction liability of “Demerol” (D-140). J. Pharmacol. exp. Ther. 75, 64–68 (1942)
Himmelsbach, C.K.: Further studies of the addiction liability of Demerol (1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester hydrochloride). J. Pharmacol. exp. Ther. 79, 5–9 (1943)
Himmelsbach, C.K.: Treatment of the morphine abstinence syndrome with a synthetic cannabis-like compound. Sth. med. J. (Bgham, Ala.) 37, 26–29 (1944)
Himmelsbach, C.K., Andrews, H.L.: Studies on the modification of the morphine abstinence syndrome by drugs. J. Pharmacol. exp. Ther. 77, 17–23 (1943)
Himmelsbach, C.K., Andrews, H.L., Felix, R.H., Oberst, F.W., Davenport, L.F.: Studies on codeine addiction. Publ. Hlth Rep. (Wash.), Suppl. 158 (1940)
Himmelsbach, C.K., Eddy, N.B., Davenport, L.F.: Studies on drug addiction. Part III. Clinical studies of drug addiction, with special reference to opium derivatives and allied synthetic substances. Publ. Hlth Rep. (Wash.), Suppl. 138 (1938)
Himmelsbach, C.K., Oberst, F.W., Brown, R.R., Williams, E.G.: Studies of the influence of prostigmine on morphine addiction. J. Pharmacol. exp. Ther. 76, 50–56 (1942)
Hoffmeister, F., Wuttke, W.: Self administration: Positive and negative reinforcing properties of morphine antagonists in Rhesus monkeys. In: Braude, M.C., Harris, L.S., May, E.L., Smith, J.P., Villarreal, J.E. (Eds.): Narcotic antagonists. Advances in biochemical psychopharmacology, Vol. 8. New York: Raven Press 1974
Houde, R.W., Wallenstein, S.L., Beaver, W.T.: Clinical measurement of pain. In: deStevens, G. (Ed.): Analgetics. New York: Academic Press 1965
Houde, R.W., Wallenstein, S.L., Rogers, A.: Analgesic studies in cancer patients: Tilidine, propiram, SU-19713B, levorphanol and nalbuphine. Presented at 36th meeting, Committee on Problems of Drug Dependence, National Research Council, Mexico City, Mexico 1974
Isbell, H.: Methods and results of studying experimental human addiction to the newer synthetic analgesics. Ann. N.Y. Acad. Sci. 51, 108–122 (1948a)
Isbell, H.: Report on K-4710 (keto-bemidone, 10720). Presented at 3rd meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C. 1948 b
Isbell, H.: Addiction liability of dihydrocodeinone (No. 154). Presented at 5th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C. 1949a
Isbell, H.: Addiction liability of morphinan (NU-2206). Presented at 5th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C. 1949b
Isbell, H.: The addiction liability of some derivatives of meperidine. J. Pharmacol. exp. Ther. 97, 182–189 (1949c)
Isbell, H.: Addiction liability of the acetylmethadols. Presented at 7th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C. 1951
Isbell, H.: Activities of the NIMH Addiction Research Center, USPHS Hospital, Lexington, Kentucky. I. Clinical studies of addiction; II. Clinical investigations of barbiturate addiction; III. Addiction liabilities of l-and d-Dromoran (3-hydroxy-N-methylmorphinan); IV. Addiction liability of dl-3-methocy-N-methylmorphinan (methyl ether of Dromoran, Ro-1-5470). Presented at 9th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C. 1952 a
Isbell, H.: Studies on N-allylnormorphine. Presented at 9th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C., 1952 b
Isbell, H.: Nalline-a specific narcotic antagonist; clinical and pharmacological observations. Merck Rep. 62, 23–26 (1953a)
Isbell, H.: Studies on addiction liabilities of new agents and related work of the Research Division. Presented at 11th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Lexington, Kentucky 1953 b
Isbell, H.: Addiction liability of dihydrohydroxymorphinone (Numorphan or No. 5501). Presented at 14th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Rensselaer, New York 1954 a
Isbell, H.: Work of the NIMH Addiction Research Center, Public Health Service Hospital, Lexington, Kentucky. Presented at 13th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Nutley, New Jersey 1954 b
Isbell, H.: Withdrawal symptoms in “primary” meperidine addicts. Fed. Proc. 14, 354 (1955a)
Isbell, H.: Work of the NIMH Addiction Research Center, U.S. Public Health Service Hospital, Lexington, Kentucky, for the calendar year 1954. Presented at 15th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Lexington, Kentucky 1955 b
Isbell, H.: Attempted addiction to nalorphine. Fed. Proc. 15, 442 (1956)
Isbell, H.: Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacologia (Berl.) 1, 29–38 (1959)
Isbell, H., Belleville, R.E., Fraser, H.F., Wikler, A., Logan, C.R.: Studies on lysergic acid diethylamide (LSD-25). Effects in former morphine addicts and development of tolerance during chronic intoxication. Arch. Neurol. Psychiat. (Chic.) 76, 468–478 (1956)
Isbell, H., Eisenman, A.J.: The addiction liability of some drugs of the methadone series and 6-methyldihydromorphine. Presented at 2nd meeting, Committee on Drug Addiction and Narcotics, Washington, D.C. 1948a
Isbell, H., Eisenman, A.J.: The addiction liability of some drugs of the methadone series. J. Pharmacol. exp. Ther. 93, 305–312 (1948b)
Isbell, H., Eisenman, A.J., Wikler, A., Frank, K.: The effects of single doses of 6-dimethylamino-4-4-diphenyl-3-heptanone (amidone, methadon or 10820) on human subjects. J. Pharmacol. exp. Ther. 92, 83–89 (1948a)
Isbell, H., Fraser, H.F.: Addiction to analgesics and barbiturates. J. Pharmacol. exp. Ther., Part II, 90, 355–397 (1950)
Isbell, H., Fraser, H.F.: Actions and addiction liability of dithienylbutenylamines in man. J. Pharmacol. exp. Ther. 109, 417–421 (1953a)
Isbell, H., Fraser, H.F.: Action and addiction liabilities of Dromoran derivatives in man. J. Pharmacol. exp. Ther. 107, 524–530 (1953b)
Isbell, H., Fraser, H.F.: Addictive properties of methadone derivatives. Fed. Proc. 13, 369 (1954)
Isbell, H., Fraser, H.F.: Addiction liability of 4,4-diphenyl-6-dimethylamino-hexanone-3. J. Pharmacol. exp. Ther. 113, 29–30 (1955)
Isbell, H., Fraser, H.F.: Report on the work of the National Institute of Mental Health Addiction Research Center. Presented at 20th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C. 1959
Isbell, H., Fraser, H.F., Wikler, A.: Work of the Research Division of the National Institute of Mental Health. Demonstrations. Presented at 11th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Lexington, Kentucky 1953
Isbell, H., Miner, E.J., Logan, C.R.: Relationship of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25). Psychopharmacologia (Berl.) 1, 20–28 (1959)
Isbell, H., Vogel, V.H.: The addiction liability of methadon (amidone, Dolophine, 10820) and its use in the treatment of the morphine abstinence syndrome. Amer. J. Psychiat. 105, 909–914 (1949)
Isbell, H., Wikler, A., Eddy, N.B., Wilson, J.H., Moran, C.F.: Tolerance and addiction liability of 6-dimethylamino-4-4-diphenyl-heptanone-3 (methadon). J. Amer. med. Ass. 135, 888–894 (1947)
Isbell, H., Wikler, A., Eisenman, A.J., Frank, K., Daingerfield, M.: Liability of addiction to 6-dimethylamino-4,4-diphenyl-3-heptanone (methadon, amidone or 1082) in man. Arch. intern. Med. 82, 362–392 (1948b)
Jasinski, D.R, Griffith, J.D, Carr, C.B.: Etorphine in man. I. Subjective effects and suppression of morphine abstinence. Clin. Pharmacol. Ther. 17, 267–272 (1975a)
Jasinski, D.R., Griffith, J.D., Carr, C.B., Gorodetzky, C.W., Kullberg, M.R: Progress report from the Clinical Pharmacology Section of the Addiction Research Center. Presented at 36th Meeting, Committee on Problems of Drug Dependence, National Research Council, Mexico City, Mexico 1974
Jasinski, D.R., Griffith, J.D., Pevnick, J.S., Clark, S.G.: Progress report on studies from the Clinical Pharmacology Section of the Addiction Research Center. Presented at 37th Meeting, Committee on Problems of Drug Dependence, National Research Council, Washington, D.C. 1975b
Jasinski, D.R., Mansky, R.: The subjective effects of GPA-2087 and nalbuphine (EN-2234A). Presented at 32nd meeting, Committee on Problems of Drug Dependence, National Research Council, Washington, D.C. 1970
Jasinski, D.R., Mansky, P.A.: Evaluation of nalbuphine for abuse potential. Clin. Pharmacol. Ther. 13, 78–90 (1972)
Jasinski, D.R., Martin, W.R.: Assessment of the dependence-producing properties of dihydrocodeinone and codoxime. Clin. Pharmacol. Ther. 8, 266–270 (1967a)
Jasinski, D.R., Martin, W.R.: Evaluation of a new photographic method for assessing pupil diameters. Clin. Pharmacol. Ther. 8, 271–272 (1967b)
Jasmski, D.R., Martin, W.R., Haertzen, C.A.: The human pharmacology and abuse potential of N-allynoroxymorphone (naloxone). Presented at 29th meeting, Committee on Problems of Drug Dependence, National Research Council, Lexington, Ky. 1967a
Jasinski, D.R., Martin, W.R., Haertzen, C.A.: The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). J. Pharmacol. exp. Ther. 157, 420–426 (1967b)
Jasinski, D.R., Martin, W.R., Hoeldtke, R.: Progress report on the abuse potential of weak narcotic antagonists. Presented at 31st meeting, Committee on Problems of Drug Dependence, National Research Council, Palo Alto, Calif. 1969
Jasinski, D.R., Martin, W.R., Hoeldtke, R.D.: Effects of short-and long-term administration of pentazocine in man. Clin. Pharmacol. Ther. 11, 385–403 (1970)
Jasinski, D.R., Martin, W.R., Hoeldtke, R.D.: Studies of the dependence-producing properties of GPA-1657, profadol and propiram in man. Clin. Pharmacol. Ther. 12, 613–649 (1971a)
Jasinski, D.R., Martin, W.R., Mansky, P.A.: Progress report on the assessment of the antagonists nalbuphine and GPA-2087 for abuse potential and studies of the effects of dextromethorphan in man. Presented at 33rd Meeting, Committee on Problems of Drug Dependence, National Research Council, Toronto, Ontario, Canada 1971b
Jasinski, D.R., Martin, W.R., Sapira, J.D.: Antagonism of the subjective, behavioral, pupillary and respiratory depressant effects of cyclazocine by naloxone. Clin. Pharmacol. Ther. 9, 215–222 (1968a)
Jasinski, D.R., Martin, W.R., Sapira, J.D.: Progress report on the dependence-producing properties of GPA-1657, profadol hydrochloride (CI-572), propiram fumarate (BAY-4503) and dexoxadrol. Presented at 30th meeting, Committee on Problems of Drug Dependence, National Research Council, Indianapolis, Ind. 1968 b
Jasinski, D.R., Nutt, J.G.: Progress report on the assessment program of the NIMH Addiction Research Center. Presented at 34th meeting, Committee on Problems of Drug Dependence, National Research Council, Washington, D.C. 1972
Jasinski, D.R., Nutt, J.G.: Progress report on the clinical assessment program of the Addiction Research Center. Presented at 35th meeting, Committee on Problems of Drug Dependence, National Research Council, Chapel Hill, North Carolina 1973
Jasinski, D.R., Nutt, J.G., Carr, C.B.: Evaluation in man of the effects of a mixture of morphine and d-amphetamine (MA). Fed. Proc. 31, 530 (1972)
Jones, B.E., Martin, W.R., Isbell, H., Fraser, H.F.: Evaluation of a photographic method of estimating pupil diameter in man. Fed. Proc. 21, 326 (1962)
Kay, D.C., Gorodetzky, C.W., Martin, W.R.: Comparative effects of codeine and morphine in man. J. Pharmacol. exp. Ther. 156, 101–106 (1967)
Keats, A.S., Telford, J.: Nalorphine, a potent analgesic in man. J. Pharmacol. exp. Ther. 117, 190–199 (1956)
King, M.R., Himmelsbach, C.K., Sanders, R.S.: Dilaudid (dihydromorphinone). A review of the literature and a study of its addictive properties. Publ. Hlth Rep, Suppl. 113 (1935)
Kolb, L., Himmelsbach, C.K.: Clinical studies of drug addiction. III. A critical review of the withdrawal treatments with method of evaluating abstinence syndromes. Amer. J. Psychiat. 94, 759–797 (1938)
Kosterlitz, H.W., Waterfield, A.A., Berthoud, V.: Assessment of the agonist and antagonist properties of narcotic analgesic drugs by their actions on the morphine receptor in the guinea pig ileum. In: Braude, L.S., Harris, L.S., May, E.L., Smith, J.P., Villarreal, J.E. (Eds.): Narcotic antagonists. Advances in biochemical psychopharmacology, Vol.8. New York: Raven Press 1974
Lasagna, L., Beecher, H.K.: The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J. Pharmacol. exp. Ther. 112, 356–363 (1954)
Mansky, P.A., Jasinski, D.R.: Effects of dextromethorphan (D) in man. Pharmacologist 12, 231 (1970)
Marquardt, W.G., Martin, W.R., Jasinski, D.R.: The use of the Polaroid CU camera in pupillography. Int. J. Addict. 2, 301–304 (1967)
Martin, W.R.: Strong analgesics. In: Root, W.S., Hofman, E.G. (Eds.): Physiological pharmacology, Vol. 1. New York: Academic Press 1963
Martin, W.R.: Assessment of the dependence-producing potentiality of narcotic analgesics. In: Radouco-Thomas, C., Lasagna, L. (Eds.): International encyclopedia of pharmacology and therapeutics. Glasgow: Pergamon Press 1966
Martin, W.R.: Clinical evaluation for narcotic dependence. In: Way, E.L. (Ed.): New concepts in pain and its clinical management. Philadelphia: F. A. Davis Co. 1967a
Martin, W.R.: Opioid antagonists. Pharmacol. Rev. 19, 463–521 (1967b)
Martin, W.R.: Pharmacological redundancy as an adaptive mechanism in the central nervous system. Fed. Proc. 29, 13–18 (1970)
Martin, W.R., Eades, C.G., Thompson, W.O., Thompson, J.A., Flanary, H.G: Morphine physical dependence in the dog. J. Pharmacol. exp. Ther. 189, 759–771 (1974a)
Martin, W.R., Fraser, H.F.: A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J. Pharmacol. exp. Ther. 133, 388–399 (1961)
Martin, W.R., Fraser, H.F., Gorodetzky, C.W., Rosenberg, D.E.: Additional studies on the addictiveness of 2-cyclopropyl methyl-2’-hydroxy-5,9-dimethyl-6,7-benzomorphan (Win 20, 740, ARC-II-C-3). Presented at 26th meeting, Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C. 1964
Martin, W.R., Fraser, H.F., Gorodetzky, C.W., Rosenberg, D.E.: Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2’-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, Win 20, 740; ARC-II-C-3). J. Pharmacol. exp. Ther. 150, 426–436 (1965)
Martin, W.R., Gorodetzky, C.W.: A preliminary report on the morphine-like properties and physical dependence liability of alpha-d-acetoxy-1,2-diphenyl-3-methyl-4-pyrrolidinobutane hydrochloride (Lilly-31,518, NIH-7662, ARC-I-C-27). Presented at 27th meeting, Committee on Problems of Drug Dependence, National Research Council, Houston, Texas 1965 a
Martin, W.R., Gorodetzky, C.W.: Demonstration of tolerance to and physical dependence on N-allylnormorphine (nalorphine). Presented at 27th meeting, Committee on Problems of Drug Dependence, National Research Council, Houston, Texas 1965 b
Martin, W.R., Gorodetzky, C.W.: Demonstration of tolerance to and physical dependence on N-allynormorphine (nalorphine). J. Pharmacol. exp. Ther. 150, 437–442 (1965c)
Martin, W.R., Gorodetzky, C.W., Kay, D.C., McClane, T.K., Jasinski, D.R.: Activities of the Addiction Research Center during 1965. Presented at 28th meeting, Committee on Problems of Drug Dependence, National Research Council, New York, N.Y. 1966
Martin, W.R., Jasinski, D.R.: Physiological parameters of morphine dependence in man-tolerance, early abstinence, protracted abstinence. J. psychiat. Res. 7, 9–17 (1969)
Martin, W.R., Jasinski, D.R., Haertzen, C.A., Kay, D.C., Jones, B.E., Mansky, P.A., Carpenter, W.: Methadone-a reevaluation. Arch. gen. Psychiat. 28, 286–295 (1973a)
Martin, W.R., Jasinski, D.R., Mansky, P.A.: Characteristics of the blocking effects of EN-1639A (N-cyclopropylmethyl-7,8-dihydro-14-hydroxynormorphinone HCl). Presented at 33 rd meeting, Committee on Problems of Drug Dependence, National Research Council, Toronto, Ontario, Canada 1971
Martin, W.R., Jasinski, D.R., Mansky, P.A.: Naltrexone, an antagonist for the treatment of heroin dependence. Arch. gen. Psychiat. 28, 784–791 (1973b)
Martin, W.R., Jasinski, D.R., Sapira, J.D.: Progress report on the assessment of the ability of GPA-1657 to produce drug dependence of morphine type in man. Presented at 29th meeting, Committee on Problems of Drug Dependence, National Research Council, Lexington, Ky. 1967
Martin, W.R., Jasinski, D.R., Sapira, J.D., Flanary, H.G., Kelly, O.A., Thompson, A.K., Logan, C.R.: The respiratory effects of morphine during a cycle of dependence. J. Pharmacol. exp. Ther. 162, 182–189 (1968)
Martin, W.R., Thompson, W.O., Fraser, H.F.: Comparison of graded single intramuscular doses of morphine and pentobarbital in man. Clin. Pharmacol. Ther. 15, 623–630 (1974b)
McClane, T.K., Martin, W.R.: Subjective and physiologic effects of morphine, pentobarbital, and meprobamate. Clin. Pharmacol. Ther. 20, 192–198 (1976)
National Institute on Drug Abuse: Report on drug abuse treatment and rehabilitation services. For the CODAP National Management Central Administrative Unit. Rockville, Maryland: NIDA, August 1974
Nutt, J.G., Jasinski, D.R.: Comparison of intravenously administered methadone (ME), morphine (MO), heroin (H) and placebo (P). Fed. Proc. 32, 694 (1973)
Nutt, J.G., Jasinski, D.R.: Methadone-naloxone mixtures for use in methadone maintenance programs, I. An evaluation in man of their pharmacological feasibility. II. Demonstration of acute physical dependence. Clin. Pharmacol. Ther. 15, 156–166 (1974)
Pachter, I.J.: Synthetic 14-hydroxymorphinan narcotic antagonists. In: Braude, M.C., Harris, L.S., May, E.L., Smith, J.P., Villarreal, J.E. (Eds.): Narcotic antagonists. Advances in biochemical psychopharmacology, Vol.8. New York: Raven Press 1974
Pierson, A.K.: Assays for narcotic antagonist activity in rodents. In: Braude, M.C., Harris, L.S., May, E.L., Smith, J.P., Villarreal, J.E. (Eds.): Narcotic antagonists. Advances in biochemical psychopharmacology, Vol. 8. New York: Raven Press 1974
Rasor, R.W., Crecraft, H.J.: Addiction to meperidine (Demerol) hydrochloride. J. Amer. med. Ass. 157, 654–657 (1955)
Sapira, J.D., Ball, J.C., Cottrell, E.S.: Addiction to methadone among patients at Lexington and Fort Worth. Publ. Hlth Rep. (Wash.) 83, 691–694 (1968)
Schrappe, O.: “Physical dependence” nach chronischer Verabreichung von n-Allylnormorphin. Drug Res. 9, 130–132 (1959)
Seitner, P.G., Martin, B.C., Cochin, J., Harris, L.: Survey of analgesic drug prescribing patterns. Washington, D.C.: Drug Abuse Council, Inc. 1975
Simpson, D.: Pretreatment drug use by patients entering drug treatment programs during 1971–1973. Texas Christian University Institute of Behavioral Research Report No. 74-5, 1974
Snedecor, G.W., Cochran, W.G.: Statistical Methods. Ames, Iowa: Iowa State University Press 1973
Stephens, R.C., Weppner, R.S.: Legal and illegal use of methadone: One year later. Amer. J. Psychiat. 130, 1391–1394 (1973)
Sunshine, L.E., Slafta, J., Fleischman, E.: A comparative analgesia study of propoxyphene hydrochloride, propoxyphene napsylate and placebo. Toxicol. appl. Pharmacol. 19, 512–518 (1971)
Swanson, D.W., Weddige, R.L., Morse, R.M.: Abuse of prescription drugs. Mayo Clin. Proc. 48, 359–367 (1973)
U.S. Department of Justice, Drug Enforcement Administration: Drug Abuse Warning Network, Phase II Report, July 1973–March 1974. Washington, D.C.: U.S. Government Printing Office 1974
Villarreal, J.E., Karbowski, M.G.: The actions of narcotic antagonists in morphine-dependent Rhesus monkeys. In: Braude, M.D., Harris, L.S., May, E.L., Smith, J.P., Villarreal, J.E. (Eds.): Narcotic antagonists. Advances in biochemical psychopharmacology, Vol.8. New York: Raven Press 1974
Wallenstein, S.L., Houde, R.W., Beaver, W.T.: Analgesic studies of orally and parenterally administered morphine and codeine in patients with cancer. Fed. Proc. 26, 742 (1967)
Weppner, R.S.: “Cheap Kicks”: Codeine cough syrup abusers and some of their social characteristics. Int. J. Addict. 6, 647–660 (1971)
Wikler, A., Fraser, H.F., Isbell, H.: N-allylnormorphine: Effects of single doses and precipitation of acute “abstinence syndromes” during addiction to morphine, methadone or heroin in man (post addicts). J. Pharm. exp. Ther. 109, 8–20 (1953)
Wolbach, A.B., Fraser, H.F.: Addiction liability of ethyl 1-(2 Carbamyl-ethyl)-4-phenylpiperidine-4-carboxylate hydrochloride. Presented at the 24th meeting, Committee on Drug Addiction and Narcotics, National Research Council, New York, New York 1962
Wolbach, A.B., Fraser, H.F.: Addiction liability of I-C-26 (dextro-3-dimethylamino-1,1-diphenylbutyl ethyl sulfone hydrochloride) and I-D-20 (ethyl 1-(2-carbamethyl)-4-phenylpiperidine-4-carboxylate hydrochloride. Bull. Narcot. 14, 25–28 (1963)
Wolff, P.: The significance of codeine as a habit-forming drug. Bull. Hlth. Org. L.o.N. 7, 546–580 (1938)
Yanagita, T.: An experimental framework for evaluation of dependence liability of various types of drugs in monkeys. Bull. Narcot. 25, 57–64 (1973)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jasinski, D.R. (1977). Assessment of the Abuse Potentiality of Morphinelike Drugs (Methods Used in Man). In: Martin, W.R. (eds) Drug Addiction I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 45 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66612-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-66612-4_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66614-8
Online ISBN: 978-3-642-66612-4
eBook Packages: Springer Book Archive